Literature DB >> 9820485

Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis.

C Migliaccio1, A Nishio, J Van de Water, A A Ansari, P S Leung, Y Nakanuma, R L Coppel, M E Gershwin.   

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by the presence of antimitochondrial Abs (AMA). The autoantigens recognized by AMA are the E2 components of the pyruvate dehydrogenase complex (PDC-E2), the branched chain 2-oxoacid dehydrogenase complex E (BCOADC-E2), and the 2-oxoglutarate dehydrogenase complex E (OGDC-E2). Previous studies using murine monoclonal and human combinatorial Abs to PDC-E2 have demonstrated an intense linear staining pattern in the apical region of biliary epithelial cells (BEC) in PBC but not control liver. We therefore examined whether mAbs to the other mitochondrial autoantigens BCOADC-E2 and OGDC-E2 demonstrated disease-specific patterns of reactivity. Using an expressed recombinant "trihybrid" protein containing the lipoyl domains of PDC-E2, OGDC-E2, and BCOADC-E2, we immunized BALB/c mice to produce 35 mAbs specific for one or more of the above mitochondrial autoantigens. Seven of these mAbs uniquely stained the apical region of BEC in PBC. Of these seven, one was reactive to PDC-E2, two recognized BCOADC-E2, three were reactive to OGDC-E2, and one recognized all three Ags. Our current data demonstrate that, similar to our previous studies regarding PDC-E2, mAbs to BCOADC-E2 and OGDC-E2, or a molecule that cross-reacts with the inner lipoyl domain of all three enzymes, also show a uniquely intense staining pattern in the apical region of BEC in patients with PBC when compared with diseased controls. The abundance of such disease-specific determinants in the target cells of PBC raises interesting possibilities regarding the role of these autoantigens in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820485

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis.

Authors:  K Inamura; H Tsuji; Y Nakamoto; M Suzuki; S Kaneko
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis.

Authors:  Ourania Sfakianaki; Maria Tzardi; Argyro Voumvouraki; Aikaterini Afgoustaki; Meri Koulentaki; Elias Kouroumalis
Journal:  World J Hepatol       Date:  2013-10-27

3.  Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis.

Authors:  Guanghua Rong; Renqian Zhong; Ana Lleo; Patrick S C Leung; Christopher L Bowlus; Guo-Xiang Yang; Chen-Yen Yang; Ross L Coppel; Aftab A Ansari; Dean A Cuebas; Howard J Worman; Pietro Invernizzi; Gregory J Gores; Gary Norman; Xiao-Song He; M Eric Gershwin
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

4.  Toxoplasma gondii scavenges host-derived lipoic acid despite its de novo synthesis in the apicoplast.

Authors:  Michael J Crawford; Nadine Thomsen-Zieger; Manisha Ray; Joachim Schachtner; David S Roos; Frank Seeber
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

5.  Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.

Authors:  Ana Lleo; Christopher L Bowlus; Guo-Xiang Yang; Pietro Invernizzi; Mauro Podda; Judy Van de Water; Aftab A Ansari; Ross L Coppel; Howard J Worman; Gregory J Gores; M Eric Gershwin
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

6.  CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease.

Authors:  Guo-Xiang Yang; Yuehong Wu; Hiroki Tsukamoto; Patrick S Leung; Zhe-Xiong Lian; Daniel B Rainbow; Kara M Hunter; Gerard A Morris; Paul A Lyons; Laurence B Peterson; Linda S Wicker; M Eric Gershwin; William M Ridgway
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

7.  Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.

Authors:  Kanji Wakabayashi; Zhe-Xiong Lian; Patrick S C Leung; Yuki Moritoki; Koichi Tsuneyama; Mark J Kurth; Kit S Lam; Katsunori Yoshida; Guo-Xiang Yang; Toshifumi Hibi; Aftab A Ansari; William M Ridgway; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

8.  Apotopes and the biliary specificity of primary biliary cirrhosis.

Authors:  Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; Ross L Coppel; Ian R Mackay; Gregory J Gores; Aftab A Ansari; Judy Van de Water; M Eric Gershwin
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

9.  Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis.

Authors:  Patrick S C Leung; Lorenzo Rossaro; Paul A Davis; Ogyi Park; Atsushi Tanaka; Kentaro Kikuchi; Hiroshi Miyakawa; Gary L Norman; William Lee; M Eric Gershwin
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.